Barrett Esophagus Clinical Trial
Official title:
Acetowhitening Time as a Novel Objective Tool for the Diagnosis of High Risk Neoplasia in Barrett's Oesophagus
Acetic acid chromoendoscopy is an established standard technique used to detect dysplasia
within the gastrointestinal tract. Acetic acid spray helps to identify neoplasia by
highlighting the surface pattern, highlighting the vascular pattern and by a process known
as the aceto-whitening reaction, where tissues take acetic acid and turn white for a brief
period and then slowly revert back to a normal colour. The neoplastic surface and vascular
pattern are all very well described, and have played a big role in the recognition of early
cancer. The aceto-whitening reaction is well described but the differential in timing
between neoplastic and non-neoplastic areas is not well understood.
The investigators aim to establish the differential in the timing of the disappearance of
the aceto-whitening reaction between healthy tissue, dysplastic tissue, intramucosal cancer
and invasive cancer after acetic acid dye spray in the oesophagus and colon. By
understanding this better, the investigators may be able to predict with greater accuracy
whether a highlighted abnormal area is cancer or high grade dysplasia, or whether it is low
grade dysplasia or inflammation, which has significant prognostic implications for the
patient.
The investigators hypothesize that the differential in the timing of the disappearance of
the aceto-whitening reaction between normal and abnormal tissue could help in the detection
of gastrointestinal neoplasia.
This is a prospective pilot study. It is standard practice within our unit to use acetic
acid for the detection of neoplasia. No patient would receive any additional intervention
that would not normally be performed.
We will record the surface and vascular patterns before and after acetic acid spray. As
usual we will then apply acetic acid spray to the Barrett's epithelium and time how long it
takes for the aceto whitening to disappear. It is the timing of the disappearance that is
the key study intervention. We will biopsy these areas to confirm the diagnosis. Again this
is standard practice and no patient will be denied an intervention that is normally
performed, and no extra interventions will be performed over and above the standard clinical
practice.
We will correlate the histology to the aceto-whitening disappearance time to identify a
threshold time which can serve as a cut off between neoplastic and non-neoplastic tissue.
We hypothesise that the aceto-whitening reaction lasts much longer in the normal epithelium
of Barrett's oesophagus and colon. This reaction will be much shorter in areas with abnormal
pathology like dysplasia or cancer.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03554356 -
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
|
N/A | |
Completed |
NCT03015389 -
Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma
|
||
Completed |
NCT03434834 -
OCT Pilot in Esophagus
|
N/A | |
Terminated |
NCT04642690 -
Nitrates and IL-8 in Barrett's Esophagus
|
||
Completed |
NCT03468634 -
Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy
|
N/A | |
Recruiting |
NCT02310230 -
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
|
N/A | |
Completed |
NCT00217087 -
Endoscopic Therapy of Early Cancer in Barretts Esophagus
|
Phase 2 | |
Completed |
NCT02284802 -
Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy
|
N/A | |
Recruiting |
NCT05530343 -
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
|
N/A | |
Active, not recruiting |
NCT04151524 -
Classification of Adenocarcinoma of the Esophagogastric Junction
|
||
Completed |
NCT00955019 -
Novel Method of Surveillance in Barrett's Esophagus
|
Phase 2 | |
Terminated |
NCT00386594 -
Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
|
N/A | |
Completed |
NCT00576498 -
Novel Imaging Techniques in Barrett's Esophagus
|
N/A | |
Completed |
NCT02688114 -
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
|
N/A | |
Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
Completed |
NCT02560623 -
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT05056051 -
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT04001478 -
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
|
||
Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
Completed |
NCT04587310 -
Does Laparoscopic Sleeve Gastrectomy Lead to Barrett's Esophagus, 5-year Esophagogastroduodenoscopy Findings: A Retrospective Cohort Study
|